Lavipharm S.A. (ATH:LAVI)
Greece
· Delayed Price · Currency is EUR 1.540
+0.010 (0.65%)
Apr 29, 2026, 1:25 PM EET
Lavipharm Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 259 | 164 | 134 | 134 | 64 | 30 | Upgrade
|
| Market Cap Growth | 93.59% | 22.01% | 0.36% | 107.29% | 117.58% | 23.40% | Upgrade
|
| Enterprise Value | 285 | 191 | 157 | 161 | 98 | 66 | Upgrade
|
| Last Close Price | 1.53 | 0.97 | 0.78 | 0.78 | 0.37 | 1.58 | Upgrade
|
| PE Ratio | 43.18 | 27.34 | 14.93 | 71.42 | 77.29 | 17.20 | Upgrade
|
| PS Ratio | 4.13 | 2.62 | 2.53 | 2.79 | 1.65 | 0.75 | Upgrade
|
| PB Ratio | - | 2.90 | 2.53 | 3.12 | 1.60 | -2.98 | Upgrade
|
| P/TBV Ratio | - | 11.22 | 17.21 | 78.88 | - | - | Upgrade
|
| P/FCF Ratio | - | 30.35 | - | - | - | 13.52 | Upgrade
|
| P/OCF Ratio | - | 24.56 | 29.82 | 470.51 | 19.27 | 7.21 | Upgrade
|
| EV/Sales Ratio | 4.56 | 3.06 | 2.96 | 3.36 | 2.50 | 1.67 | Upgrade
|
| EV/EBITDA Ratio | 21.65 | 14.81 | 17.69 | 19.44 | 19.70 | 12.35 | Upgrade
|
| EV/EBIT Ratio | 30.52 | 22.18 | 31.17 | 34.11 | 24.01 | 14.66 | Upgrade
|
| EV/FCF Ratio | - | 35.47 | - | - | - | 30.17 | Upgrade
|
| Debt / Equity Ratio | 0.58 | 0.58 | 0.64 | 0.76 | 0.92 | -3.76 | Upgrade
|
| Debt / EBITDA Ratio | 2.39 | 2.39 | 3.53 | 3.64 | 6.68 | 6.28 | Upgrade
|
| Debt / FCF Ratio | 6.08 | 6.08 | - | - | - | 17.03 | Upgrade
|
| Net Debt / Equity Ratio | 0.47 | 0.47 | 0.54 | 0.56 | 0.47 | -3.59 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.07 | 2.07 | 3.20 | 2.91 | 3.82 | 6.66 | Upgrade
|
| Net Debt / FCF Ratio | 4.95 | 4.95 | -5.51 | -6.39 | -0.59 | 16.28 | Upgrade
|
| Asset Turnover | 0.49 | 0.49 | 0.44 | 0.42 | 0.47 | 0.77 | Upgrade
|
| Inventory Turnover | 1.49 | 1.49 | 1.52 | 1.93 | 2.18 | 2.70 | Upgrade
|
| Quick Ratio | 0.65 | 0.65 | 0.56 | 0.66 | 0.70 | 0.35 | Upgrade
|
| Current Ratio | 1.21 | 1.21 | 1.15 | 1.27 | 1.00 | 0.63 | Upgrade
|
| Return on Equity (ROE) | 9.23% | 9.23% | 18.10% | 4.74% | 6.25% | - | Upgrade
|
| Return on Assets (ROA) | 4.22% | 4.22% | 2.62% | 2.57% | 3.04% | 5.46% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.96% | 7.06% | 6.79% | 4.58% | 4.02% | 11.00% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.00% | 10.00% | 5.80% | 6.00% | 5.90% | 38.60% | Upgrade
|
| Earnings Yield | 2.32% | 3.66% | 6.70% | 1.40% | 1.29% | 5.82% | Upgrade
|
| FCF Yield | - | 3.29% | -3.84% | -2.82% | -50.06% | 7.40% | Upgrade
|
| Dividend Yield | 1.38% | - | 2.58% | - | - | - | Upgrade
|
| Payout Ratio | - | 56.48% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | - | 0.06% | -0.17% | -681.40% | -26.42% | - | Upgrade
|
| Total Shareholder Return | 1.38% | 0.06% | 2.40% | -681.40% | -26.42% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.